loading
Precedente Chiudi:
$3.49
Aprire:
$3.5
Volume 24 ore:
476.90K
Relative Volume:
0.31
Capitalizzazione di mercato:
$91.40M
Reddito:
-
Utile/perdita netta:
$-40.19M
Rapporto P/E:
-1.4844
EPS:
-2.3444
Flusso di cassa netto:
$-38.49M
1 W Prestazione:
+8.07%
1M Prestazione:
-75.66%
6M Prestazione:
-56.82%
1 anno Prestazione:
-57.92%
Intervallo 1D:
Value
$3.27
$3.56
Intervallo di 1 settimana:
Value
$2.77
$3.67
Portata 52W:
Value
$2.66
$16.00

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Name
Nome
Elicio Therapeutics Inc
Name
Telefono
(857) 209-0050
Name
Indirizzo
451 D STREET, 5TH FLOOR, BOSTON
Name
Dipendente
33
Name
Cinguettio
Name
Prossima data di guadagno
2026-08-06
Name
Ultimi documenti SEC
Name
ELTX's Discussions on Twitter

Compare ELTX vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ELTX icon
ELTX
Elicio Therapeutics Inc
3.48 91.40M 0 -40.19M -38.49M -2.3444
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
485.39 123.19B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
664.52 69.67B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
877.62 54.58B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
298.76 39.89B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
186.88 39.73B 742.00K -1.37B -1.07B -7.0731

Elicio Therapeutics Inc Stock (ELTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-04-15 Iniziato Ladenburg Thalmann Buy
2026-03-10 Iniziato Rodman & Renshaw Buy

Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie

pulisher
Jul 10, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 10, 2026
pulisher
Jul 10, 2026

Enterprise value to revenue forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView

Jul 10, 2026
pulisher
Jul 10, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elicio Therapeutics, Inc. (ELTX) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jul 10, 2026
pulisher
Jul 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc.ELTX - PR Newswire

Jul 09, 2026
pulisher
Jul 09, 2026

Why Is ELTX Stock Falling Today? - Stocktwits

Jul 09, 2026
pulisher
Jul 08, 2026

[SCHEDULE 13G/A] Elicio Therapeutics, Inc. Amended Passive Investment Disclosure - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Jul 08, 2026
pulisher
Jul 08, 2026

2026-07-08 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Shareholders to Learn More About the Investigation | NDAQ:ELTX | Press Release - Stockhouse

Jul 08, 2026
pulisher
Jul 07, 2026

ELICIO THERAPEUTICS ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING - Moomoo

Jul 07, 2026
pulisher
Jul 06, 2026

Elicio Therapeutics closes $15 million stock offering - Investing.com

Jul 06, 2026
pulisher
Jul 06, 2026

Elicio Therapeutics Closes $15 Million Registered Direct Offering - marketscreener.com

Jul 06, 2026
pulisher
Jul 06, 2026

Elicio Therapeutics closes $15 million stock offering By Investing.com - Investing.com South Africa

Jul 06, 2026
pulisher
Jul 06, 2026

Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering - The Manila Times

Jul 06, 2026
pulisher
Jul 06, 2026

Elicio closes $15M stock sale to fund KRAS cancer trial work - Stock Titan

Jul 06, 2026
pulisher
Jul 05, 2026

Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirt - The National Law Review

Jul 05, 2026
pulisher
Jul 04, 2026

Enterprise value to EBIT forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView

Jul 04, 2026
pulisher
Jul 04, 2026

Elicio Therapeutics (ELTX) Stock Forum and Discussion - Moomoo

Jul 04, 2026
pulisher
Jul 04, 2026

Price to sales forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView

Jul 04, 2026
pulisher
Jul 03, 2026

Enterprise value to EBITDA forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView

Jul 03, 2026
pulisher
Jul 02, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Elicio Therapeutics, Inc. (ELTX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics stock tumbles on $15M offering - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics stock tumbles on $15M offering By Investing.com - Investing.com India

Jul 02, 2026
pulisher
Jul 02, 2026

Form 424B5 Elicio Therapeutics Inc For: 2 July By Investing.com - Investing.com India

Jul 02, 2026
pulisher
Jul 02, 2026

Form 424B5 Elicio Therapeutics, - StreetInsider

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics (ELTX) raises ~$15.0M via 4.38M-share placement - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment - Yahoo Finance

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics raises $15M in registered direct offering By Investing.com - Investing.com Australia

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics Prices $15 Million Registered Direct Offering at $3.43; Signs Purchase, Placement Pacts - TradingView

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics (ELTX) prices $15M registered direct equity offering - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics Prices $15 Million Direct Offering - marketscreener.com

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio locks in $15M to fund Phase 1 KRAS cancer trial - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics prices $15M stock offering to fund cancer immunotherapy trials. - Pluang

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics raises $15M in registered direct offering - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - The Manila Times

Jul 02, 2026
pulisher
Jul 02, 2026

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering - GlobeNewswire Inc.

Jul 02, 2026
pulisher
Jul 01, 2026

Price to book forward of Elicio Therapeutics, Inc. – NASDAQ:ELTX - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jul 01, 2026
pulisher
Jul 01, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jul 01, 2026
pulisher
Jun 30, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Stockholders to Connect - ACCESS Newswire

Jun 30, 2026
pulisher
Jun 30, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therap - The National Law Review

Jun 30, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc.(NasdaqCM:ELTX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics Joins Russell 2000 and 3000 Indexes (ELTX) - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics added to Russell 2000 and 3000 indexes - Investing.com

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com South Africa

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc.(NasdaqCM:ELTX) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes - The Manila Times

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Elicio Therapeutics, Inc.(NasdaqCM: ELTX) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Elicio Therapeutics Inc Azioni (ELTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$56.43
price down icon 2.64%
$115.61
price down icon 2.24%
$35.97
price down icon 2.28%
$68.27
price down icon 10.83%
ONC ONC
$298.70
price down icon 1.36%
$186.88
price down icon 2.22%
Capitalizzazione:     |  Volume (24 ore):